The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)

Exclusion Criteria

• •1. Congestive heart failure, uncontrolled coronary heart disease, arrhythmia and heart infarction less than 12 months
• •2. Active GVHD
• •3. History of severe pulmonary dysfunction
• •4. Active malignant tumor need be treated at the same time
• •5. Uncontrolled active acute/chronic infection
• •6. Severe autoimmune diseases or congenital immunodeficiency
• •7. Untreated active hepatitis
• •8. HIV-positive, AIDS patients and syphilis infection
• •9. History of severe allergies to biological products
• •10. Patients with a history of mental illness
• •11. Pregnant or lactating women; (female participants of reproductive potential must have a negative serum or urine pregnancy test)
• •12. Researchers think of that does not fit to participate in the study, or other cases that affect the clinical trial results